The World Health Organization has laid down its first guidelines for GLP-1 drugs like Wegovy and Zepbound. Advertisement.

The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said this ...

Experts say the official recommendation reemphasizes the game-changing ability of GLP-1 medications, but stress that diet and exercise are integral to an effective treatment plan for obesity. The ...

The new World Health Organization guideline supports using GLP-1 drugs for long-term obesity care, emphasizing lifestyle, behavioral therapy.

The World Health Organization is officially backing popular weight-loss drugs like Ozempic and Wegovy. The WHO published new guidelines about glucagon-like peptide-1 (GLP-1) medications in the medical ...

The WHO has just released landmark global guidelines recommending for the first time that GLP-1 medicines may be used for long-term treatment of obesity in adults. The move comes as obesity rates ...

GLP-1 drugs have rapidly shifted from niche diabetes treatments to blockbuster weight loss injections, reshaping everything from cardiology guidelines to grocery bills. As prescriptions soar, a ...

Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.

A new World Health Organization (WHO) guideline recommending GLP-1s for obesity treatment along with recent efforts to reduce the drugs’ costs are unlikely to change US obesity practice — but actions ...

Following a warning by a UK regulator about a small risk of severe acute pancreatitis with weight loss jabs, Medical News Today spoke to 3 experts about who is most at risk and whether the benefits ...

The World Health Organisation (WHO) has released a guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic disease. In September 2025, the WHO added GLP-1 ...

American Academy of Pediatrics guidelines that set off a new era in obesity treatment — and a national debate about whether children should be prescribed weight loss drugs — may have been shaped by ...